• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home The Classics Cardiology Classics

The ROMICAT 1 trial: Coronary computed tomographic angiography highly sensitive for acute coronary syndrome in patients with acute chest pain [Classics Series]

by2 Minute Medicine's The Classics in Radiology
December 27, 2018
in Cardiology Classics, Imaging Classics, The Classics
Reading Time: 3 mins read
Share on FacebookShare on Twitter

The following study summary is an excerpt from the book 2 Minute Medicine’s The Classics in Radiology: Summaries of Clinically Relevant & Recent Landmark Studies, 1e (The Classics Series).

1. In patients presenting with chest pain and a low to intermediate risk of acute coronary syndrome (ACS), computed tomographic coronary angiography (CTCA) demonstrated high sensitivity and negative predictive value for acute coronary syndrome. 

Original Date of Publication: May 2009 

Study Rundown: Chest pain is one of the most common patient complaints and accounts for over 100 million emergency department visits every year in the U.S. alone. Most patients presenting with chest pain have not suffered an ACS, though many are admitted to hospital for further monitoring and testing. CTCA is a rapid test that can identify significant stenoses in the coronary arteries, though its utility in chest pain evaluation was unclear at the time of this study, having only been assessed in several small studies.

The Rule Out Myocardial Infarction using Computer Assisted Tomography 1 (ROMICAT 1) trial was a blinded prospective cohort study that sought to determine whether CTCA was useful in assessing patients with acute chest pain and low to intermediate risk of ACS. The absence of coronary artery disease on CTCA demonstrated a sensitivity of 100% and a negative predictive value (NPV) of 100% for ACS. Thus, CTCA may be of high utility in evaluating patients with chest pain in the emergency department and facilitate more rapid discharge of patients with low to intermediate likelihood of ACS. Additional radiation exposure remains one of the limitations inherent in this technology, though decreasingly so with modern techniques including prospective electrocardiogram (ECG) triggering.

In-Depth [prospective cohort]: This study examined 368 patients who were >18 years of age, presented to the emergency department with chest pain lasting >5 minutes in the previous 24 hours, had initially normal troponin levels and ECG, were suspected to have ischemic chest pain, were admitted to the hospital to rule out myocardial infarction (MI), and were able to perform a breath hold of 10-15 seconds. Exclusion criteria included initial elevation in troponin or CK-MB levels, new diagnostic ECG changes (ST-segment elevation or depression ≥1 mm or T wave inversions >4 mm in 2 contiguous leads), hemodynamic or clinical instability, known allergy to iodinated contrast, and history of established coronary artery disease (previous stent implantation or coronary bypass grafting).

RELATED REPORTS

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

Coronary CT-angiography-guided management improves outcomes in patients with stable chest pain

Colchicine not beneficial after acute myocardial infarction for reducing cardiovascular events

CT imaging was performed using a 64-slice scanner (Sensation 64, Siemens Medical Solutions) with iodinated contrast. Patients with a heart rate >60 beats/min received intravenous metoprolol 5-20 mg, unless their systolic blood pressure was <100 mmHg. Axial images were reconstructed using a retrospectively ECG-gated algorithm. The presence of significant coronary artery stenosis was defined as any luminal obstruction >50% in any coronary segment.

By CTCA, 183 patients (50%) were found to have no coronary disease. In this cohort, identifying no plaque demonstrated a sensitivity and NPV of 100% (95%CI 89-100%) and 100% (95%CI 98-100%), respectively, for ACS. Finding any plaque yielded a specificity of 54% (95%CI 49-60%) for ACS with a positive predictive value (PPV) of 17%. The absence of significant coronary stenosis demonstrated a sensitivity of 77% (95%CI 59-90%) and a NPV of 98%, while the presence of coronary stenosis demonstrated a specificity of 87% (95%CI 83-90%) and a PPV of 35%. Additionally, both plaque and stenosis, as assessed on CTA, predicted ACS independent of cardiovascular risk factors or TIMI risk score (AUC 0.88, 0.82 versus 0.63, respectively; all p < 0.05).

Click to read the study in the Journal of the American College of Cardiology

Hoffmann U, Bamberg F, Chae CU, Nichols JH, Rogers IS, Seneviratne SK, et al. Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain. The ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) Trial. J Am Coll Cardiol. 2009 May 5;53(18):1642–50.

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute coronary syndrometroponin
Previous Post

Quick Take: Christmas, National Holidays, Sport Events, and Time Factors as Triggers of Acute Myocardial Infarction: SWEDEHEART Observational Study 1998-2013

Next Post

Meta-analysis shows optimal FiO2 for resuscitation of preterm infants remains equivocal

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

October 30, 2025
Physician visual assessment of coronary stenosis severity overestimates quantitative coronary angiography
Cardiology

Coronary CT-angiography-guided management improves outcomes in patients with stable chest pain

August 29, 2026
PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study
Cardiology

Colchicine not beneficial after acute myocardial infarction for reducing cardiovascular events

August 29, 2026
Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease
Cardiology

Ticagrelor monotherapy reduces bleeding risk compared to dual antiplatelet therapy for patients following coronary stenting

September 25, 2024
Next Post
Rapid genetic testing useful for diagnosis of critically ill children

Meta-analysis shows optimal FiO2 for resuscitation of preterm infants remains equivocal

Stroke associated with acute and persistent cognitive decline

Quick Take: Sex and Race Differences in the Association of Incident Ischemic Stroke with Risk Factors

Modified FOLFIRINOX results in longer disease-free survival in metastatic pancreatic cancer patients compared to gemcitabine

Modified FOLFIRINOX results in longer disease-free survival in metastatic pancreatic cancer patients compared to gemcitabine

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.